Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.
about
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Efficacy and safety of daily m ...... sis of five phase III studies.
@ast
Efficacy and safety of daily m ...... sis of five phase III studies.
@en
type
label
Efficacy and safety of daily m ...... sis of five phase III studies.
@ast
Efficacy and safety of daily m ...... sis of five phase III studies.
@en
prefLabel
Efficacy and safety of daily m ...... sis of five phase III studies.
@ast
Efficacy and safety of daily m ...... sis of five phase III studies.
@en
P2093
P2860
P356
P1476
Efficacy and safety of daily m ...... sis of five phase III studies.
@en
P2093
Andrea Tubaro
Christopher R Chapple
Emad Siddiqui
José E Batista
Mary Beth Blauwet
Matthias Oelke
Moses Huang
Sender Herschorn
Victor W Nitti
P2860
P304
P356
10.1177/1756287217702797
P577
2017-05-10T00:00:00Z